Mahathir Bayena

Alvotech (NASDAQ:ALVO) announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio (vedolizumab) for intravenous administration.

The Bhutanese government has sold another 738 Bitcoin worth approximately $44.9 million, extending a months-long trend of reducing its cryptocurrency holdings to finance major economic development projects.

Long-time Bitcoin critic Peter Schiff has unexpectedly sided with the crypto industry by rejecting calls from Jamie Dimon to subject stablecoin issuers to the same regulatory framework as traditional banks.

Aureka (ASX:AKA) announced a breakthrough at its 100% owned Irvine Gold Project within the Stawell Corridor.

Ethereum has retested the key $1,500 support zone after losing several major technical levels, placing the second-largest cryptocurrency at a critical juncture for its medium-term trend.

Singapore-based crypto travel platform Travala has launched a new protocol that allows artificial intelligence agents to search, reserve and pay for hotel bookings using USD Coin on the Base blockchain.

Bitcoin's network hashrate has fallen from 1,030 exahash per second (EH/s) on May 28 to 885 EH/s, reflecting a sharp contraction in mining activity as bitcoin prices retreat to levels last seen in February.

BluGlass (ASX:BLG) has capitalised on its recently expired listed options, bringing in a total of $6.6 million in gross proceeds.

NextNRG (NASDAQ:NXXT) announced preliminary, unaudited financial results for May 2026, highlighting a 41% year-over-year increase in revenue to $9.3 million, compared to $6.6 million in the same month last year.

Amneal Pharmaceuticals (NASDAQ:AMRX) has announced encouraging interim data from the Phase 4 ELEVATE-PD clinical trial, which evaluates the efficacy and safety of CREXONT (carbidopa and levodopa) extended-release capsules in patients living with Parkinson’s disease.